Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Type 2 diabetes clinical trial success rates U.S. 2006-2015, by phase and indication

Clinical trial success rates of novel type 2 diabetes drugs between 2006 and 2015, by phase and indication

by Matej Mikulic, last edited Apr 18, 2019
Type 2 diabetes clinical trial success rates U.S. 2006-2015, by phase and indication This statistic depicts the percentage of U.S. type 2 diabetes clinical trials for novel drugs that were successful in the period from 2006 to 2015, by phase and indication. Among diabetes NME/biologics just 4.8 percent were successful from phase I to approval.
Show more

Clinical trial success rates of novel type 2 diabetes drugs between 2006 and 2015, by phase and indication

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Clinical trials"
  • R&D overview
  • Top R&D companies
  • Clinical studies
  • Participation
  • Costs and market
  • Success rates
  • Approvals, launches, setbacks
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.